Study to Evaluate Effect of Everolimus in Progression of Graft Vascular Illness on Patients With Heart Transplant
Status:
Unknown status
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if there is a significantly less incidence of major
clinical events due to graft vascular illness in recipients of a cardiac transplant on
treatment with an immunosuppressive combination, which includes Everolimus, compared to those
that continue the previously used immunosuppressive treatment.